ProfileGDS5678 / 1439043_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 46% 46% 46% 46% 46% 44% 49% 48% 46% 46% 45% 47% 45% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1150746
GSM967853U87-EV human glioblastoma xenograft - Control 23.0634846
GSM967854U87-EV human glioblastoma xenograft - Control 33.0751646
GSM967855U87-EV human glioblastoma xenograft - Control 43.0249746
GSM967856U87-EV human glioblastoma xenograft - Control 53.0191446
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1219344
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2349849
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1367548
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.047646
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0555846
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0563445
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0656847
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0657745
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0631846